United Homes Group stock plunges after Nikki Haley, directors resign
Investing.com -- 10x Genomics (NASDAQ:TXG) stock rose 8% after announcing a partnership with AI company Anthropic to integrate its single cell and spatial analysis tools into Anthropic’s Claude for Life Sciences platform.
The collaboration aims to make 10x Genomics’ advanced biological analysis capabilities more accessible to researchers through natural language interaction rather than complex coding. Using Anthropic’s Claude AI assistant, scientists will be able to perform analytical tasks like read alignment, clustering, and other analyses through a conversational interface.
According to the announcement, researchers can now interact with their 10x datasets directly through Claude for Life Sciences. The integration with 10x’s Cloud Analysis is designed to lower barriers for new users while scaling to meet the needs of advanced research teams.
"Our collaboration with Anthropic makes the power of single cell and spatial biology accessible to every scientist through Claude for Life Sciences," said Serge Saxonov, Co-Founder and CEO of 10x Genomics in the press release. "Now, researchers can begin to interact with their data through natural conversation, without needing a computational background."
Eric Kauderer-Abrams, Head of Life Sciences and Biology at Anthropic, noted that the partnership demonstrates "what’s possible when we remove the technical barriers that have limited access to the analysis tools that labs run on."
The companies indicated this collaboration marks the beginning of a broader effort to make 10x’s biological analysis tools more intuitive through AI integration.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.